IBRX ImmunityBio reports narrower than projected Q4 2025 per share loss while its stock holds steady for the trading session Is Orchid ORC stock positioned for growth Orchid posts 152 EPS beat tops analyst forecast iShares Latin America 40 ETF ILF Emerging Market Leadership Amid Narrow 2026 Market Breadth PECO Phillips Q1 2026 earnings vastly outperform analyst forecasts shares rise modestly after results Nike Inc NKE Q3 FY2026 Results Disappoint Sparking Debate Over DipBuying Opportunity Amid Extended Turnaround Timeline Why Palmer PSBD could deliver where others fall short Slight Rise 20260503 HR Healthcare posts 745 percent Q4 2025 EPS surprise yet shares dip 07 percent in daily trading BJ BJs notches narrow Q1 2026 earnings beat shares edge down 04 percent in muted trading Target Corporation TGT Bullish Thesis Underscores Structural Turnaround Potential and Attractive RiskReward Profile CAC Camden Natl posts nearexpected Q4 2025 EPS shares slip 04 on mild investor caution EQT Corporation EQT delivers 11 percent Q1 2026 EPS beat shares drop 236 percent in todays trading Is MacroGenics MGNX stock showing downside risk Q4 2025 Better Than Expected